CRRT的适应症(席修明)概要
CRRT的适应症 席修明
美国社区中ARF的发病率
急性肾功能衰竭的流行病
统计2001年全美国出院病人,根据ICD-9-CM的诊断标准
共收院患者,ARF患者558032,
平均19.2/1000
平均住院天数-不同器官衰竭Clin J Am Soc Nephrol 2006;1:43-51
CRRT 的临床应用多种多样
欧洲、澳洲和亚洲 ICU 的病人几乎是唯一的选择(澳洲90%)
Mehta 1996调查美国2000名肾脏病医生,应用CRRT的ARF病人小于25%
1 Liano F Kidney International 1996;50:811-818
2 ColeL Am J Respir Crit Care Med 2000;162:191-196
3 Mehta RL American J of Nephrology 1999; 19:377-382
B.E.S.T. Kidney analyzes data from 54 centers in 23 countries around the world. In this first international epidemiological study of current practice in RRT,
Rinaldo Bellomo and other investigators have examined nearly 30,000 ICU patients and found close to 2,000 patients with ARF.
Remarkably, the incidence of ARF is quite similar across regions, although treatment patterns and outcome vary.
Vol. 294 No. 7, August 17, 2005 ??JAMA ???Online Features Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study
Regional difference in choice of RRT(Best kidney study)
Difference of practice for RRT in the world(Best kidney study)
Who manages renal replacement therapy in the ICU ?(From 54 centers in the BEST kidney study)
IRRT CRRT
Who prescribes RRT?
Nephrologists 22(40.7%) 11(20.4%)
Intensivists 12(22.2%) 32(59.3%)
Both 14 (25.9%) 11(20.4%)
Not available 6(11.1%)
Who primes circuit?
Dialysis nurses 36(66.7%) 9(16.7%)
ICU nurses 7(13%) 32(59.3%)
Nephrologists 0 2(3.7%)
Intensivists 1(1.9%) 6(11.1%)
Management of severe acute renal
您可能关注的文档
- cns解剖概要.ppt
- COPD并呼吸衰竭营养支持进展概要.ppt
- COFPresentation(I)-V5概要.ppt
- COPD诊断于治疗概要.ppt
- COPD慢性阻塞性肺疾病概要.ppt
- Corey+有机合成五大策略概要.ppt
- COPD---pbl概要.ppt
- CP4-8布鲁菌病概要.ppt
- CP02—199期末家长会概要.ppt
- CPA少见肿瘤概要.ppt
- 2026《面向多样性的隐私保护推荐方法概述》7800字.docx
- 2026《基于PLC的智能立体停车场的控制系统设计》7200字.docx
- 2026《太赫兹技术概述》4200字.docx
- 2026《分布式电力系统经济调度研究现状国内外文献综述》2800字.docx
- 2026《曲美家具集团股份有限公司成本管理存在的问题及对策》5600字.docx
- 2026《基于肌肉信号的人体运动研究国内外文献综述》3400字.doc
- 2026《基于城市林学植物配置问题研究》7200字.docx
- 2026《社区重点人群管理平台设计与实现》7900字.docx
- 2026《区县医院内网的设计与实施研究》6900字.doc
- 2026《静电除尘的原理及高频电源的优势综述》3100字.doc
原创力文档

文档评论(0)